Read more
20:48 · 28 April 2026

Spotify Earnings: Profitability up, price down

The Swedish audio distribution platform, listed on a U.S. exchange, fell more than 10% after publishing its Q1 2026 results. Despite the extreme market reaction, the figures do not seem to justify it - at least not at first glance.

  • Earnings per share (EPS) came in clearly above expectations, reaching as much as €3.45 versus market expectations of around €2.95.
  • Revenue was merely solid, almost exactly in line with the consensus, totaling €4.53 billion.

Additional positives for the company include:

  • Premium subscribers increased by 9% year over year to 293 million—close to market expectations.
  • Revenue from premium users rose by 10% year over year to €4.15 billion.
  • Monthly active users increased to 761 million—also above expectations.
  • Gross margin rose to a record 33%, beating the company’s own guidance.
  • Operating profit was also record-high, rising to €715 million with a 15.8% margin.
  • Free cash flow (FCF) was record-high as well, at €824 million.

Could anything spoil such strong results? The market seems to be focusing almost exclusively on guidance.

The company announced that Q2 operating profit is expected to reach €630 million. That is a decline versus Q1 and materially below market expectations of about €674 million. Revenue is expected to increase to €4.8 billion, with monthly active users rising to 778 million.

This suggests the company is not expecting a structural deterioration in business conditions, but rather signaling a temporary dip in profitability - albeit from a very high base.

At the same time, the company is showing it can steadily grow revenue, and the user metrics are also providing reasons for optimism.

While a significant quarter-on-quarter drop in profitability is a notable short-term issue, the magnitude of the sell-off appears, in the context of this release, overdone.

SPOT.US (D1)

 

The second half of 2025 proved very difficult for Spotify. The company’s valuation fell by as much as 45%, wiping out the entire gain from early 2025. The depth of this decline may raise questions—questions shared by analysts at investment firms. Given the time frame, the drop in the company’s valuation may have been driven mainly by capital rotating into AI-focused companies. Source: xStation5

28 April 2026, 17:33

US OPEN: Concerns about OpenAI’s drag the whole market lower

22 April 2026, 18:13

US OPEN: Wall Street Shrugs Off Iran Concerns, Eyes Tesla Results

22 April 2026, 15:13

Tesla preview: Narrative matters more than numbers

22 April 2026, 11:53

Intel preview: Is there still room for gains?

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer are risky. XTB is regulated by the CMA.